1) 安保雅博,角田 亘(編著).上肢痙縮に対するボツリヌス治療とリハビリテーション.東京:金原出版;2012.
2) Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67(2):206-7.
3) 米本恭三,石神重信,近藤 徹.関節可動域表示ならびに測定法(平成7年4月改訂).リハビリテーション医学1995;32(4):207-17.
4) Brunnstrom S. Movement Therapy in Hemiplegia:A Neurophysiologic Approach. New York:Harper & Row;1971.
5) Brashear A, Zafonte R, Corcoran M, et al. Inter- and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb poststroke spasticity. Arch Phys Med Rehabil 2002;83(10):1349-54.
6) Fugl-Meyer AR, Jääskö L, Leyman I, et al. The post-stroke hemiplegic patient. 1. a method for evaluation of physical performance. Scand J Rehabil Med 1975;7(1):13-31.
7) 石川 篤,角田 亘,田口健介・他.本邦の生活に即した脳卒中後上肢麻痺に対する主観的評価スケール作成の試み—日常生活における「両手動作」と「片手動作」に注目して.慈恵医大誌2010;125(5):159-67.
8) Hara T, Abo M, Hara H, et al. The effect of repeated Botulinum toxin a therapy combined with intensive rehabilitation on lower limb spasticity in post-stroke patients. Toxins (Basel) 2018;10(9). E349. doi:10.3390/toxins10090349.
9) Takekawa T, Kakuda W, Taguchi K, et al. Botulinum toxin type A injection, followed by home-based functional training for upper limb hemiparesis after stroke. Int J Rehabil Res 2012;35(2):146-52.
10) Hara T, Abo M, Hara H, et al. Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on upper and lower limb spasticity in post-stroke patients. Int J Neurosci 2017;127(6):469-78.
11) Pathak MS, Nguyen HT, Graham HK, et al. Management of spasticity in adults:practical application of botulinum toxin. Eur J Neurol 2006;13 (Suppl 1):42-50.
12) Takekawa T, Abo M, Ebihara K, et al. Long-term effects of injection of botulinum toxin type A combined with home-based functional training for post-stroke patients with spastic upper limb hemiparesis. Acta Neurol Belg 2013;113(4):469-75.